{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:54:10Z","timestamp":1762782850665,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11992-2","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:46:29Z","timestamp":1762782389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment patterns of empirical antibiotic therapies for critically ill patients with sepsis: a cross-sectional study in Vietnam"],"prefix":"10.1186","volume":"25","author":[{"given":"Thi Thanh Huong","family":"Trinh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Tham","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh-Hoang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoc Trinh","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"10219","key":"11992_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(19)32989-7.","journal-title":"Lancet"},{"issue":"12","key":"11992_CR2","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1097\/01.Ccm.0000098031.24329.10","volume":"31","author":"J Garnacho-Montero","year":"2003","unstructured":"Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31(12):2742\u201351. https:\/\/doi.org\/10.1097\/01.Ccm.0000098031.24329.10.","journal-title":"Crit Care Med"},{"issue":"2","key":"11992_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/eja.0000000000001140","volume":"37","author":"O Lindberg","year":"2020","unstructured":"Lindberg O, De Geer L, Chew MS. Nonadherence to antibiotic guidelines in patients admitted to ICU with sepsis is associated with increased mortality: A registry-based, retrospective cohort study. Eur J Anaesthesiol. 2020;37(2):113\u201320. https:\/\/doi.org\/10.1097\/eja.0000000000001140.","journal-title":"Eur J Anaesthesiol"},{"issue":"11","key":"11992_CR4","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1097\/ccm.0000000000000516","volume":"42","author":"C Vazquez-Guillamet","year":"2014","unstructured":"Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med. 2014;42(11):2342\u20139. https:\/\/doi.org\/10.1097\/ccm.0000000000000516.","journal-title":"Crit Care Med"},{"issue":"6","key":"11992_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","volume":"18","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596. https:\/\/doi.org\/10.1186\/s13054-014-0596-8.","journal-title":"Crit Care"},{"issue":"11","key":"11992_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"issue":"9","key":"11992_CR7","doi-asserted-by":"publisher","first-page":"e1003787","DOI":"10.1371\/journal.pmed.1003787","volume":"18","author":"SCH Wen","year":"2021","unstructured":"Wen SCH, Ezure Y, Rolley L, et al. Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLoS Med. 2021;18(9):e1003787. https:\/\/doi.org\/10.1371\/journal.pmed.1003787.","journal-title":"PLoS Med"},{"key":"11992_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1186\/1471-2458-13-1158","volume":"13","author":"KV Nguyen","year":"2013","unstructured":"Nguyen KV, Thi Do NT, Chandna A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13:1158. https:\/\/doi.org\/10.1186\/1471-2458-13-1158.","journal-title":"BMC Public Health"},{"issue":"5","key":"11992_CR9","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1016\/s2214-109x(21)00024-3","volume":"9","author":"NTT Do","year":"2021","unstructured":"Do NTT, Vu HTL, Nguyen CTK, et al. Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach. Lancet Glob Health. 2021;9(5):e610\u20139. https:\/\/doi.org\/10.1016\/s2214-109x(21)00024-3.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"11992_CR10","doi-asserted-by":"publisher","first-page":"dlab048","DOI":"10.1093\/jacamr\/dlab048","volume":"3","author":"N Nguyen-Hoang","year":"2021","unstructured":"Nguyen-Hoang N, Bui QTH. Assessing the appropriateness of antimicrobial therapy in patients with sepsis at a Vietnamese National hospital. JAC Antimicrob Resist. 2021;3(2):dlab048. https:\/\/doi.org\/10.1093\/jacamr\/dlab048.","journal-title":"JAC Antimicrob Resist"},{"issue":"6","key":"11992_CR11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644\u201355. https:\/\/doi.org\/10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"key":"11992_CR12","volume-title":"H\u01b0\u1edbng d\u1eabn s\u1eed d\u1ee5ng kh\u00e1ng Sinh [Antibiotic Guideline]","author":"Vietnam Ministry of Health","year":"2015","unstructured":"Vietnam Ministry of Health. H\u01b0\u1edbng d\u1eabn s\u1eed d\u1ee5ng kh\u00e1ng sinh [Antibiotic Guideline]. Vietnamese: Medical Publishing House; 2015."},{"key":"11992_CR13","unstructured":"Gilbert DN, Chambers HF, Saag MS, et al. The Sanford guide to antimicrobial therapy 2021. 51st ed. Antimicrobial Therapy, Inc.; 2021."},{"key":"11992_CR14","unstructured":"Gilbert DN, Chambers HF, Saag MS, et al. The Sanford guide to antimicrobial therapy 2022. 52st ed. Antimicrobial Therapy, Inc.; 2022."},{"key":"11992_CR15","unstructured":"Gilbert DN, Chambers HF, Saag MS, et al. The Sanford guide to antimicrobial therapy 2023. 53st ed. Antimicrobial Therapy, Inc.; 2023."},{"issue":"9403","key":"11992_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363. https:\/\/doi.org\/10.1016\/s0140-6736(03)15268-3.","journal-title":"Lancet"},{"issue":"1","key":"11992_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12872-025-04679-8","volume":"25","author":"HH Nguyen","year":"2025","unstructured":"Nguyen HH, Trinh NTT, Tran MH, Pham HT. Masked uncontrolled hypertension in patients with end-stage kidney disease on in-center Hemodialysis. BMC Cardiovasc Disord. 2025;25(1):245. https:\/\/doi.org\/10.1186\/s12872-025-04679-8.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"11992_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.2","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1\u2013138. https:\/\/doi.org\/10.1038\/kisup.2012.2.","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"11992_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-Value. Ann Intern Med. 2017;167(4):268\u201374. https:\/\/doi.org\/10.7326\/m16-2607.","journal-title":"Ann Intern Med"},{"issue":"3","key":"11992_CR20","doi-asserted-by":"publisher","first-page":"106379","DOI":"10.1016\/j.ijantimicag.2021.106379","volume":"58","author":"V D\u2019Onofrio","year":"2021","unstructured":"D\u2019Onofrio V, Meersman A, Magerman K, et al. Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes. Int J Antimicrob Agents. 2021;58(3):106379. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106379.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"11992_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13054-018-2091-0","volume":"22","author":"R Ferrer","year":"2018","unstructured":"Ferrer R, Mart\u00ednez ML, Gom\u00e0 G, et al. Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study. Crit Care. 2018;22(1):167. https:\/\/doi.org\/10.1186\/s13054-018-2091-0.","journal-title":"Crit Care"},{"issue":"1","key":"11992_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000545150","volume":"11","author":"N Nguyen-Hoang","year":"2025","unstructured":"Nguyen-Hoang N, Zhang W, Koeze J, Snieder H, Keus E, Lunter G. Development and validation of a clinical prediction model for stages of acute kidney injury in critically ill patients. Kidney Dis. 2025;11(1):226\u201339. https:\/\/doi.org\/10.1159\/000545150.","journal-title":"Kidney Dis"},{"issue":"9","key":"11992_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1089\/mdr.2020.0454","volume":"27","author":"P Kovacevic","year":"2021","unstructured":"Kovacevic P, Jandric M, Kovacevic T, et al. Impact of checklist for early recognition and treatment of acute illness on treatment of critically ill septic patients in a Low-Resource medical intensive care unit. Microb Drug Resist. 2021;27(9):1203\u20136. https:\/\/doi.org\/10.1089\/mdr.2020.0454.","journal-title":"Microb Drug Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11992-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11992-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11992-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:46:31Z","timestamp":1762782391000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11992-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11992"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11992-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Medicine and Pharmacy at Ho Chi Minh City, under approval number 1018\/HDDD-DHYD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1535"}}